252 related items for PubMed ID: 16126050
1. Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome.
Rüth EM, Kemper MJ, Leumann EP, Laube GF, Neuhaus TJ.
J Pediatr; 2005 Aug; 147(2):202-7. PubMed ID: 16126050
[Abstract] [Full Text] [Related]
2. Long-term outcomes in idiopathic nephrotic syndrome: from childhood to adulthood.
Skrzypczyk P, Panczyk-Tomaszewska M, Roszkowska-Blaim M, Wawer Z, Bienias B, Zajgzkowska M, Kilis-Pstrusinska K, Jakubowska A, Szczepaniak M, Pawlak-Bratkowska M, Tkaczyk M.
Clin Nephrol; 2014 Mar; 81(3):166-73. PubMed ID: 24361057
[Abstract] [Full Text] [Related]
3. Steroid-sensitive nephrotic syndrome: from childhood to adulthood.
Fakhouri F, Bocquet N, Taupin P, Presne C, Gagnadoux MF, Landais P, Lesavre P, Chauveau D, Knebelmann B, Broyer M, Grünfeld JP, Niaudet P.
Am J Kidney Dis; 2003 Mar; 41(3):550-7. PubMed ID: 12612977
[Abstract] [Full Text] [Related]
4. Recurrence of severe steroid dependency in cyclosporin A-treated childhood idiopathic nephrotic syndrome.
Kemper MJ, Kuwertz-Broeking E, Bulla M, Mueller-Wiefel DE, Neuhaus TJ.
Nephrol Dial Transplant; 2004 May; 19(5):1136-41. PubMed ID: 14993510
[Abstract] [Full Text] [Related]
5. Linear growth of children with nephrotic syndrome: effect of alkylating agents.
Padilla R, Brem AS.
Pediatrics; 1989 Sep; 84(3):495-9. PubMed ID: 2771553
[Abstract] [Full Text] [Related]
6. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus.
Sinha MD, MacLeod R, Rigby E, Clark AG.
Nephrol Dial Transplant; 2006 Jul; 21(7):1848-54. PubMed ID: 16311257
[Abstract] [Full Text] [Related]
7. Cyclophosphamide therapy in frequently relapsing nephrotic syndrome with and without steroid dependence.
Srivastava RN, Agarwal RK, Choudhry VP, Moudgil A, Bhuyan UN, Sunderam KR.
Int J Pediatr Nephrol; 1985 Jul; 6(4):245-50. PubMed ID: 4093243
[Abstract] [Full Text] [Related]
8. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
Kyrieleis HA, Levtchenko EN, Wetzels JF.
Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840
[Abstract] [Full Text] [Related]
9. [Treatment of corticoid-resistant nephrotic syndrome: a still unresolved problem].
Damiani B, Giani M, Consalvo G, Carcano A, Ghio L, Edefonti A.
Pediatr Med Chir; 1995 May; 17(1):9-15. PubMed ID: 7739938
[Abstract] [Full Text] [Related]
10. Remission induced by chlorambucil in steroid-responsive, frequently relapsing nephrotic syndrome that relapsed after cyclophosphamide.
Bailey RR.
N Z Med J; 1989 Jul 26; 102(872):379-81. PubMed ID: 2797556
[Abstract] [Full Text] [Related]
11. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
Nephrol Dial Transplant; 2005 Nov 26; 20(11):2433-8. PubMed ID: 16204303
[Abstract] [Full Text] [Related]
12. Family structure and the course of steroid-sensitive nephrotic syndrome.
Soliday E, Lande MB.
Pediatr Nephrol; 2002 Jan 26; 17(1):41-4. PubMed ID: 11793133
[Abstract] [Full Text] [Related]
13. Beneficial effect of chlorambucil in steroid-dependent and cyclophosphamide-resistant minimal change nephrotic syndrome.
Ueda N, Takahashi K, Akioka Y, Morooka M, Ogawa A, Tsuzuki K.
J Nephrol; 2009 Jan 26; 22(5):610-5. PubMed ID: 19809993
[Abstract] [Full Text] [Related]
14. Long-term effects of cyclophosphamide therapy in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome.
Cammas B, Harambat J, Bertholet-Thomas A, Bouissou F, Morin D, Guigonis V, Bendeddouche S, Afroukh-Hacini N, Cochat P, Llanas B, Decramer S, Ranchin B.
Nephrol Dial Transplant; 2011 Jan 26; 26(1):178-84. PubMed ID: 20610527
[Abstract] [Full Text] [Related]
15. Follow-up of linear growth of body height in children with nephrotic syndrome.
Hung YT, Yang LY.
J Microbiol Immunol Infect; 2006 Oct 26; 39(5):422-5. PubMed ID: 17066206
[Abstract] [Full Text] [Related]
16. [Cyclosporin A versus cyclophosphamide in the treatment of nephrotic syndrome in children].
Podracká L, Böör A, Sasinka M.
Cas Lek Cesk; 2008 Oct 26; 147(1):38-43. PubMed ID: 18323041
[Abstract] [Full Text] [Related]
17. Prognosis in steroid-treated idiopathic nephrotic syndrome in adults. Analysis of major predictive factors after ten-year follow-up.
Idelson BA, Smithline N, Smith GW, Harrington JT.
Arch Intern Med; 1977 Jul 26; 137(7):891-6. PubMed ID: 879928
[Abstract] [Full Text] [Related]
18. Levamisole treatment in steroid sensitive nephrotic syndrome.
Alshaya HO, Kari JA.
Saudi Med J; 2002 Sep 26; 23(9):1101-4. PubMed ID: 12370722
[Abstract] [Full Text] [Related]
19. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
Goumenos DS, Ahuja M, Davlouros P, El Nahas AM, Brown CB.
Clin Nephrol; 2006 May 26; 65(5):317-23. PubMed ID: 16724651
[Abstract] [Full Text] [Related]
20. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
Goumenos DS, Katopodis KP, Passadakis P, Vardaki E, Liakopoulos V, Dafnis E, Stefanidis I, Vargemezis V, Vlachojannis JG, Siamopoulos KC.
Am J Nephrol; 2007 May 26; 27(3):226-31. PubMed ID: 17389782
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
